Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.019 | 0.7 |